etoposide has been researched along with Epstein-Barr Virus Infections in 84 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.19) | 18.2507 |
2000's | 26 (30.95) | 29.6817 |
2010's | 38 (45.24) | 24.3611 |
2020's | 19 (22.62) | 2.80 |
Authors | Studies |
---|---|
Hiraoka, E; Iwanami, K; Matsuo, Y; Oda, R | 1 |
Song, Y; Wang, J; Wang, Y; Wang, Z; Wu, L | 1 |
Chen, J; Fan, S; Jiang, F; Liu, X; Liu, Z; Sun, Y; Xiao, J | 1 |
Chang, KC; Chen, JS; Cheng, CN; Chu, WY | 1 |
Chen, L; Chu, X; Liu, X; Wang, Y; Xu, L | 1 |
Li, Z; Qin, Y; Sang, W; Song, X; Sun, C; Tu, D; Wang, X; Xu, K; Xu, L; Yan, D; Yin, W; Zeng, L; Zhang, M | 1 |
Chen, L; Wang, J; Wang, Z | 1 |
Chiattone, CS; Culler, HF; da Siqueira, SAC; de Oliveira Costa, R; de Pádua Covas Lage, LA; Machado, PPF; Miranda, E; Miyashiro, DR; Pereira, J; Reichert, CO; Rocha, V; Sanches, JA | 1 |
Chen, C; Gan, YZ; Jia, Y; Jin, YB; Li, C; Li, GM | 1 |
Ando, T; Katsuya, H; Kidoguchi, K; Kimura, S; Kishimori, C; Kizuka-Sano, H; Kubota, Y; Nishioka, A; Ohno, H; Yamaguchi, K | 1 |
Chinceşan, MI; Mărginean, MO; Molnar, E | 1 |
Itabashi, T; Itoh, Y; Migita, M; Tanabe, Y; Ueda, T; Yamanishi, S | 1 |
Argiolas, D; Carta, E; Ibba, S; Mascia, G; Piredda, GB | 1 |
Aouidane, S; Belaaloui, G; Hamizi, K | 1 |
Jin, Z; Wang, Y; Wang, Z; Wei, N | 1 |
Au-Yeung, R; Chan, TSY; Ip, AHW; Kwong, YL; Pang, AWK | 1 |
Liao, M; Yu, J | 1 |
Huang, Z; Xie, J | 1 |
Xu, XJ; Yan, WL; Yang, SL; Zhao, FY | 1 |
Abe, Y; Ikeda, M; Ishida, T; Miyazaki, K; Oba, R; Shingaki, S; Suzuki, K; Takei, T; Tsukada, N; Yoshiki, Y | 1 |
Arai, A; Imadome, K; Miura, K; Namiki, T; Tokoro, S; Watanabe, K; Yokozeki, H | 1 |
Ehl, S | 1 |
Hope, AJ; Papp, S; Perez-Ordóñez, B; Wasserman, JK | 1 |
Imadome, KI; Kanegane, H; Kawano, Y; Kodama, Y; Nakagawa, S; Nakazawa, Y; Nishikawa, T; Okamoto, Y; Saito, A; Yatsushiro, Y | 1 |
Fan, L; Li, JY; Li, W; Liang, JH; Lu, L; Xu, W; Zhu, HY | 1 |
Jin, Z; Wang, J; Wang, Y; Wang, Z; Wu, L; Zhang, J | 1 |
Song, Y; Wang, Y; Wang, Z | 1 |
Goda, F; Otaka, Y; Sakurai, Y; Sato, M; Soma, H; Watanabe, T | 1 |
Su, Y; Zhang, L; Zhang, R; Zhou, X | 1 |
Mayson, E; Saverimuttu, J; Warburton, P | 1 |
Asano, T; Ishii, E; Kanegane, H; Kogawa, K; Kudo, K; Morimoto, A; Oda, M; Ohga, S; Ohta, S; Sato, H; Wakiguchi, H | 1 |
Lee, JC; Lerner, A; Pestana, JB; Tapan, U | 1 |
Amorosa, V; Frank, D; Harrison, N; Shah, NN; Stonecypher, M; Svoboda, J | 1 |
Thia, K; Trapani, JA; Voskoboinik, I | 1 |
Kheradpour, A; Rowsell, EH; Wang, J; Weiss, LM; Zhang, H; Zuppan, CW | 1 |
Chen, J; Gao, Z; Huang, W; Jin, Z; Pei, R; Wang, J; Wang, Y; Wang, Z; Wei, N; Wu, L; Zeng, X; Zhang, J | 1 |
Ikebe, T; Ogata, M; Saburi, Y; Sasaki, H | 1 |
Fukayama, M; Koda, K; Tajima, S; Takanashi, Y | 1 |
Rosen, D; Sinno, MG; Wittler, R | 1 |
Feng, DN; Pan, H; Song, L; Sun, LR | 1 |
Lai, W; Wang, J; Wang, Y; Wang, Z; Wu, L; Zhang, J | 1 |
Hasegawa, D; Imadome, KI; Ishida, T; Kosaka, Y; Maruyama, A; Nagase, H; Takeda, H; Tanaka, T; Uetani, Y; Yamaguchi, H; Yokoi, T | 1 |
Chen, JY; Lu, C; Tang, X; Wang, JW | 1 |
Coppo, P; Dartigues, P; Gorin, NC; Poujol-Robert, A; Serrate, C; Silva-Moreno, M; Sokol, H | 1 |
Chang, SE; Choi, JH; Kim, CH; Lee, DW; Lee, MW; Lee, WJ; Moon, KC; Won, CH | 1 |
Abe, Y; Idutsu, K; Kiyasu, J; Kotoh, K; Nagasawa, E; Nishimura, J; Ohga, S; Ohtsuka, R; Sada, E; Shiratsuchi, M; Takayanagi, R | 1 |
Dzieciatkowski, T; Jedrzejczak, WW; Luczak, M; Przybylski, M; Zduńczyk, D | 1 |
Fukuhara, N; Harigae, H; Ichikawa, S; Ishizawa, K; Kameoka, J; Kohata, K; Nakajima, S; Okitsu, Y; Onishi, Y; Suzuki, M; Yamamoto, J | 1 |
Imashuku, S | 1 |
Ozdemirli, M; Sathiyamoorthy, S; Shad, A | 1 |
Abe, Y; Doi, T; Hara, T; Ishimura, M; Miyamoto, T; Ohga, S; Shiraishi, A; Takada, H; Takimoto, T | 1 |
Papavassiliou, P; Sebastian, S; Wang, E | 1 |
Fukushima, N; Hasegawa, Y; Hashimoto, C; Hyo, R; Ishida, F; Isobe, Y; Ito, Y; Izutsu, K; Kawa, K; Kimura, H; Kobayashi, H; Maeda, Y; Nakamura, S; Okamura, S; Oshimi, K; Suzuki, R; Suzumiya, J; Takizawa, J; Yamaguchi, M | 1 |
Al, J; Huang, Z; Liu, C; Qin, Q; Shen, K; Shen, Y; Xie, Z; Xu, J; Yang, S | 1 |
Arai, A; Fujiwara, S; Imadome, K; Kurata, M; Miura, O; Murakami, N; Nogami, A | 1 |
Yamaguchi, M | 1 |
Fukayama, M; Kurokawa, M; Nakamura, F; Takazawa, Y; Uni, M; Yoshimi, A | 1 |
Advani, R; Ambinder, RF; Bartlett, NL; Cheson, BD; Fisher, RI; Gascoyne, RD; Gellert, LL; Gordon, LI; Hong, F; Horning, SJ; Hsieh, WS; Kahl, BS; Kanakry, JA; Lemas, MV; Li, H; Miller, TP; Stiff, P; Tan, KL | 1 |
Berkow, RL; Hilliard, LM; Watts, RG | 1 |
Hino, K; Kawakami, K; Matsuda, I; Nakamaki, T; Ota, H; Shiozawa, E; Tomoyasu, S | 1 |
Hibi, S; Imashuku, S; Kawano, F; Kuriyama, K; Masuda, S; Miyagawa, A; Morimoto, A; Nakao, T; Nakao, Y; Sakai, R; Tabata, Y; Teramura, T; Yakushijin, K; Yasuda, N | 1 |
Brunet, S; Esteve, J; Feliu, E; Fernández-Abellán, P; Ribera, JM; Sanz, MA; Xicoy, B | 1 |
Henter, JI; Hibi, S; Imashuku, S; Ishida, Y; Morimoto, A; Otoh, Y; Sawada, M; Tabata, Y; Tanaka, H; Tauchi, H; Teramura, T; Watanabe, A | 1 |
Imashuku, S; Kikuchi, A; Konishi, K; Kuroda, H; Maeda, Y; Tamura, S; Teramura, T | 1 |
Ejiri, M; Hara, S; Harima, A; Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A | 1 |
Eden, OB; Ng, A; Ravetto, PF; Taylor, GM; Wynn, RF | 1 |
Kang, JH; Lee, GK; Lee, JS; Park, HJ | 1 |
Cho, JH; Kim, HS; Ko, YH; Park, CS | 1 |
Bader, P; Boppana, S; Dormann, S; Fisch, P; Goebel, H; Jung, A; Kontny, U; Niemeyer, C; Peters, A; Strahm, B; Werner, M | 1 |
Culligan, DJ; Johnston, PW; Milner, BJ; Mittal, S | 1 |
Hasegawa, M; Hayakawa, I; Ikeda, H; Oishi, N; Sato, S; Shirasaki, F; Takehara, K | 1 |
Inoue, M; Kawa, K; Koyama, M; Sawada, A; Yasui, M | 1 |
Abe, T; Arai, K; Arakawa, H; Asami, K; Hasegawa, D; Henter, JI; Hibi, S; Hisakawa, H; Ichimi, R; Igarashi, N; Imashuku, S; Iwai, A; Kataoka, S; Kato, M; Kawasaki, H; Kosaka, Y; Maeda, N; Maruhashi, K; Miyashita, H; Ohara, T; Sako, M; Sano, K; Sotomatsu, M; Tanizawa, A | 1 |
Hashida, T; Hibi, S; Imashuku, S; Ishimoto, K; Itoh, E; Kawano, F; Tabata, Y; Tsunamoto, K | 1 |
Hirata, M; Kanda, M; Kikuchi, M; Kumagawa, M; Nagano, M; Nawa, Y; Ohshima, K; Suzumiya, J; Tamura, K | 1 |
Sakai, C; Takagi, T; Tamaru, J; Tsujimura, H | 1 |
Kirov, I; Lones, MA; Neudorf, S; Said, JW; Shintaku, IP | 1 |
Hibi, S; Imashuku, S; Ishii, E; Kato, M; Kinugawa, N; Kuriyama, K; Sako, M; Teramura, T | 1 |
Arai, K; Fukayama, M; Imashuku, S; Ito, E; Kitazawa, J; Yokoyama, M | 1 |
Barber, GN; Boise, LH; Cabral, L; Deyev, VV; Harrington, WJ; Liu, LH; Podack, ER; Scott, D; Toomey, NL; Wood, C | 1 |
Emmenegger, U; Neftel, KA; Spaeth, PJ | 1 |
Hibi, S; Imashuku, S; Ito, E; Kitazawa, J; Kuriyama, K; Morimoto, A; Teramura, T | 1 |
Arai, T; Hanada, R; Ida, K; Inatomi, J; Kawaguchi, H; Kikuchi, A; Kishimoto, H; Oh-Ishi, T; Taketani, T; Yamamoto, K | 1 |
Broxson, EH; Dole, MG; Dunkel, IJ; Filippa, DA; George, D; Heath, JA; Lyden, D | 1 |
9 review(s) available for etoposide and Epstein-Barr Virus Infections
Article | Year |
---|---|
[Ruxolitinib as an effective treatment for panniculitis associated hemophagocytic syndrome: A report of 2 cases and literature review].
Topics: Aged; Anti-Bacterial Agents; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Exanthema; Female; Ferritins; Fibrinogen; Glucocorticoids; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Panniculitis; Prednisone | 2022 |
[Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Daunorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Lymphohistiocytosis, Hemophagocytic; Male; Neoplasms, Second Primary; Risk Assessment; Treatment Outcome; Tretinoin | 2013 |
Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature.
Topics: Epstein-Barr Virus Infections; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Lymphohistiocytosis, Hemophagocytic; Topoisomerase II Inhibitors | 2016 |
Clinically Mild Encephalitis/Encephalopathy With a Reversible Splenial Lesion Accompanied by Epstein-Barr Virus Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature.
Topics: Bone Marrow; Corpus Callosum; Cyclosporine; Delirium; Dexamethasone; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Encephalitis; Epstein-Barr Virus Infections; Etoposide; Humans; Hyponatremia; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Neuroimaging; Prognosis; Pulse Therapy, Drug | 2017 |
Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Epstein-Barr Virus Infections; Etoposide; Evidence-Based Medicine; Female; Herpesvirus 4, Human; Humans; Immunotherapy; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Odds Ratio; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Treatment Outcome | 2012 |
Current and future management of NK/T-cell lymphoma based on clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Chemoradiotherapy; Clinical Trials as Topic; Dexamethasone; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Neoplasm Staging; Nose Neoplasms | 2012 |
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Heart Transplantation; Humans; Ifosfamide; Immunosuppression Therapy; Kidney Transplantation; Leucovorin; Liver Transplantation; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Remission Induction; Retrospective Studies; Transplantation; Treatment Outcome; Vincristine | 2003 |
Outcome of clonal hemophagocytic lymphohistiocytosis: analysis of 32 cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aneuploidy; Bone Marrow Transplantation; Child; Child, Preschool; Clone Cells; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Epstein-Barr Virus Infections; Etoposide; Female; Gene Rearrangement, T-Lymphocyte; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Japan; Male; Prednisolone; Prognosis; Treatment Outcome | 2000 |
Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Colonic Diseases; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Doxorubicin; Duodenal Ulcer; Epstein-Barr Virus Infections; Etoposide; Gastrointestinal Hemorrhage; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Neuroblastoma; Orbital Neoplasms; Prion Diseases; Transplantation Conditioning; Transplantation, Autologous; Ulcer; Vincristine | 2000 |
6 trial(s) available for etoposide and Epstein-Barr Virus Infections
Article | Year |
---|---|
L-DEP regimen is effective as an initial therapy for adult EBV-HLH.
Topics: Adult; Asparaginase; Epstein-Barr Virus Infections; Etoposide; Ferritins; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Prospective Studies; Triglycerides | 2022 |
Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Topics: Adrenal Cortex Hormones; Age of Onset; Antineoplastic Agents, Phytogenic; Asian People; Bilirubin; Child; Child, Preschool; Cyclosporine; Data Collection; Disease-Free Survival; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Infant; Japan; Lymphohistiocytosis, Hemophagocytic; Remission Induction; Retrospective Studies; Survival Rate | 2014 |
PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cisplatin; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Polyethylene Glycols; Prednisone; Remission Induction; Salvage Therapy; Transplantation Conditioning; Treatment Outcome; Young Adult | 2016 |
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nasal Mucosa; Neutropenia; Prognosis; Prospective Studies; Steroids; Treatment Outcome; Young Adult | 2012 |
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoadjuvant Therapy; North America; Prednisone; Prognosis; Sensitivity and Specificity; Vinblastine; Vincristine; Young Adult | 2013 |
Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Epstein-Barr Virus Infections; Etoposide; Female; Follow-Up Studies; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Risk Assessment | 2002 |
69 other study(ies) available for etoposide and Epstein-Barr Virus Infections
Article | Year |
---|---|
Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient.
Topics: Adult; Child; Cyclosporine; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Male | 2021 |
Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis.
Topics: Epstein-Barr Virus Infections; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Retrospective Studies | 2021 |
Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation with Cocktail Conditioning Regimen for the Treatment of Pediatric Patients with Chronic Active Epstein-Barr Virus: A Retrospective Observational Study.
Topics: Antilymphocyte Serum; Busulfan; Child; Cyclophosphamide; Cytarabine; Epstein-Barr Virus Infections; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous | 2022 |
Lymphoma-based therapy for refractory or relapsed Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in children.
Topics: Child; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Retrospective Studies | 2022 |
Successful treatment of hemophagocytic syndrome in a patient with T cell lymphoma, EBV infection, and bone marrow necrosis: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Glucocorticoids; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Rituximab; Treatment Outcome; Vincristine | 2022 |
l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
Topics: Animals; Apoptosis; Asparaginase; Burkitt Lymphoma; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2022 |
High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project.
Topics: Asparaginase; Brazil; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Retrospective Studies | 2022 |
Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.
Topics: Abnormal Karyotype; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Chromosomes, Human, Pair 19; Chromosomes, Human, Pair 22; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Prednisone; Rituximab; RNA, Neoplasm; RNA, Viral; Translocation, Genetic; Vincristine | 2020 |
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a small child: A case report.
Topics: Antibiotic Prophylaxis; Blood Component Transfusion; Child, Preschool; Combined Modality Therapy; Dexamethasone; Diagnosis, Differential; Epstein-Barr Virus Infections; Etoposide; Female; Glucocorticoids; Humans; Lymphohistiocytosis, Hemophagocytic | 2020 |
Changes in Cytokine Profile during Initial Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus.
Topics: Child, Preschool; Cytokines; Epstein-Barr Virus Infections; Etoposide; Humans; Immunoglobulins, Intravenous; Immunotherapy; Lymphohistiocytosis, Hemophagocytic; Male; Treatment Outcome | 2020 |
Hemophagocytic Lymphohistiocytosis in Renal Transplant Recipients: A 2-Case Report.
Topics: Biopsy; Bone Marrow; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Fever; Humans; Immunologic Factors; Kidney Transplantation; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Pancytopenia; Rituximab; Sepsis | 2020 |
Etoposide-based therapy for severe forms of COVID-19.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Humans; Influenza, Human; Lymphohistiocytosis, Hemophagocytic; Models, Theoretical; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2 | 2020 |
Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Dacarbazine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Treatment Outcome; Vinblastine; Young Adult | 2020 |
Unique evolution of angioimmunoblastic T cell lymphoma to Epstein-Barr virus-positive plasma cell myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Lenalidomide; Lymphoma, T-Cell; Male; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prednisolone; Vincristine | 2020 |
Secondary Leukemia in a Patient With EBV-HLH Carrying Heterozygous STXBP2 Variant.
Topics: Child, Preschool; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Leukemia, Promyelocytic, Acute; Lymphohistiocytosis, Hemophagocytic; Male; Munc18 Proteins | 2022 |
Ruxolitinib in conjunction with the HLH-94 protocol for Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in the intensive care unit: A case report.
Topics: Adolescent; Clinical Protocols; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Herpesvirus 4, Human; Humans; Induction Chemotherapy; Intensive Care Units; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Nitriles; Polyethylene Glycols; Pyrazoles; Pyrimidines; Treatment Outcome | 2021 |
Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.
Topics: Acute Kidney Injury; Child, Preschool; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Nitriles; Pyrazoles; Pyrimidines | 2022 |
Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy.
Topics: Adult; Cyclosporine; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Infectious Mononucleosis; Lymphohistiocytosis, Hemophagocytic; Pregnancy; Treatment Outcome | 2017 |
Chronic active Epstein-Barr virus infection with cutaneous lymphoproliferation: haemophagocytosis in the skin and haemophagocytic syndrome.
Topics: Adolescent; Adult; Chronic Disease; Cyclophosphamide; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Humans; Immunohistochemistry; Lymphohistiocytosis, Hemophagocytic; Male; Prednisolone; Skin Diseases | 2018 |
Etoposide for HLH: the limits of efficacy.
Topics: Epstein-Barr Virus Infections; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic | 2017 |
Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Epstein-Barr Virus Infections; Etoposide; Humans; Male; Nasopharyngeal Neoplasms; Tuberous Sclerosis | 2018 |
Epstein-Barr Virus (EBV)-induced B-cell Lymphoproliferative Disorder Mimicking the Recurrence of EBV-associated Hemophagocytic Lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Dexamethasone; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Rituximab; T-Lymphocytes | 2019 |
The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell Lymphoma Treated with Dose-Adjusted EPOCH.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Copy Number Variations; DNA, Viral; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Lymphocyte Count; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2019 |
Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein-Barr virus.
Topics: Child; Chronic Disease; DNA, Viral; Drug Resistance, Viral; Epstein-Barr Virus Infections; Etoposide; Fever; Ganciclovir; Herpesvirus 4, Human; Humans; Male; Methylprednisolone; Nitriles; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Recurrence; Splenomegaly; Viral Load; Viremia | 2019 |
Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Survival Rate; Young Adult | 2019 |
[Case report: a case of Epstein-Barr virus associated hemophagocytic syndrome with reversible leukoencephalopathy in the splenium of the corpus callosum].
Topics: Corpus Callosum; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Leukoencephalopathies; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Young Adult | 2013 |
Two-faced haemophagocytic lymphohistiocytosis: comparative review of two cases of adult haemophagocytic lymphohistiocytosis.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Biopsy, Fine-Needle; Cyclosporine; Dexamethasone; Diagnosis, Differential; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytes; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Male; Middle Aged; Rituximab; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Epstein-Barr virus-associated diffuse large B-cell lymphoma arising in atrial myxoma: a proposal for a modified therapeutic approach.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Etoposide; Fatal Outcome; Heart Atria; Heart Neoplasms; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Immunohistochemistry; Interferon Regulatory Factors; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Myxoma; Prednisone; Rituximab; Vincristine; Viral Proteins | 2015 |
Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
Topics: Adrenal Cortex Hormones; Adult; Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Diagnostic Imaging; Doxorubicin; Early Diagnosis; Epstein-Barr Virus Infections; Etoposide; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, AIDS-Related; Lymphoma, Primary Effusion; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Vincristine; Viremia | 2014 |
Familial haemophagocytic lymphohistiocytosis: Australian experience and perspectives.
Topics: Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Male | 2014 |
Cytotoxic Molecule-positive Epstein-Barr Virus-associated Peripheral T-cell Lymphoma in a 20-Month-old Child: A Case Report and Review of the Literature.
Topics: Age of Onset; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Diagnostic Errors; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Granzymes; Herpesvirus 4, Human; Humans; Infant; Lymph Nodes; Lymphoma, T-Cell, Peripheral; Male; Otitis; Perforin; Poly(A)-Binding Proteins; Prednisolone; Remission Induction; T-Cell Intracellular Antigen-1; T-Lymphocytes, Cytotoxic; Vincristine | 2015 |
[Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Topics: Adolescent; Adult; Aged; Child; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2015 |
Bilateral psoas muscle lymphoma: an unusual presentation of EBV-positive diffuse large B-cell lymphoma of the elderly.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Muscle Neoplasms; Prednisone; Psoas Muscles; Radiography; Rituximab; Vincristine | 2015 |
Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Asparaginase; Diagnosis, Differential; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Risk; Steroids | 2015 |
Concomitant Presentation of Hemophagocytic Lymphohistiocytosis and Posttransplant Lymphoproliferative Disease-Like Lymphoma in a Mildly Immunosuppressed Leukemia Patient: An Unusual Association.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunocompromised Host; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mercaptopurine; Methotrexate; Multiple Organ Failure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rituximab; Treatment Failure; Vincristine; Viral Load | 2016 |
Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Cytarabine; Epstein-Barr Virus Infections; Etoposide; Gene Rearrangement; Genes, Immunoglobulin Heavy Chain; Herpesvirus 4, Human; Humans; Immunohistochemistry; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Neoplasms, Second Primary; Polymerase Chain Reaction; Prednisone; Radiotherapy, Adjuvant; Receptors, Antigen, T-Cell; Rituximab; Tomography, X-Ray Computed; Tongue | 2017 |
Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Crohn Disease; Drug Therapy, Combination; Epstein-Barr Virus Infections; Etoposide; Female; Glucocorticoids; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Middle Aged; Rituximab | 2009 |
Dermatopathic lymphadenitis with generalized erythroderma in a patient with epstein-barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Dermatitis, Exfoliative; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Lymphadenitis; Lymphohistiocytosis, Hemophagocytic; Middle Aged | 2010 |
[Five adult cases of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Topics: Adolescent; Adult; Cell Proliferation; Early Diagnosis; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Male; Plasmapheresis; Remission Induction; T-Lymphocytes; Young Adult | 2010 |
Microbiological findings and treatment of EBV-associated hemophagocytic lymphohistiocytosis: a case report.
Topics: Adolescent; Bone Marrow; Cyclosporine; DNA, Viral; Drug Therapy, Combination; Epstein-Barr Virus Infections; Etoposide; Fever; Herpesvirus 4, Human; Humans; Immunophenotyping; Lymphatic Diseases; Lymphohistiocytosis, Hemophagocytic; Male; Skin; Skin Ulcer; Steroids | 2010 |
Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Ifosfamide; Injections, Spinal; Leukemia, Large Granular Lymphocytic; Leukemic Infiltration; Methotrexate; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Prednisone; Radiography; Remission Induction; Subarachnoid Hemorrhage; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2010 |
Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclosporine; Epstein-Barr Virus Infections; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins; Lymphohistiocytosis, Hemophagocytic; Neoplasm Staging; Risk Factors; Treatment Outcome | 2011 |
Acute promyelocytic leukemia following chemotherapy for EBV-associated hemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; In Situ Hybridization, Fluorescence; Infant; Karyotyping; Leukemia, Promyelocytic, Acute; Lymphatic Diseases; Lymphohistiocytosis, Hemophagocytic; Male; Oncogene Proteins, Fusion; Translocation, Genetic | 2011 |
Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Epstein-Barr Virus Infections; Etoposide; Female; Follow-Up Studies; Herpesvirus 4, Human; Humans; Immunotherapy; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Stem Cell Transplantation; Treatment Outcome; Young Adult | 2012 |
A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstei
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunophenotyping; Ki-1 Antigen; Lewis X Antigen; Lymphoma, Large B-Cell, Diffuse; Prednisone; Procarbazine; Reed-Sternberg Cells; Remission Induction; Vincristine | 2012 |
Sequential monitoring of serum IL-6, TNF-α, and IFN-γ levels in a CAEBV patient treated by plasma exchange and immunochemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclosporine; Disseminated Intravascular Coagulation; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Interferon-gamma; Interleukin-6; Lymphohistiocytosis, Hemophagocytic; Middle Aged; Plasma Exchange; Prednisolone; Tumor Necrosis Factor-alpha | 2012 |
Successful allogeneic stem cell transplantation for Lennert lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Melphalan; Methotrexate; Middle Aged; Nitrosourea Compounds; Pharyngitis; Prednisolone; Recurrence; Rituximab; Salvage Therapy; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 2013 |
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
[Severe type of Epstein-Barr virus associated hemophagocytic syndrome successfully treated with T-COP-E and splenectomy].
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Prednisolone; Splenectomy; Vincristine | 2003 |
Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Male; Retrospective Studies; Treatment Outcome | 2003 |
Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Cause of Death; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Dexamethasone; Drug Therapy, Combination; Epstein-Barr Virus Infections; Etoposide; Female; Follow-Up Studies; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Immunoglobulins, Intravenous; Immunotherapy; Infant; Japan; Male; Peripheral Blood Stem Cell Transplantation; Prognosis; Prospective Studies; Remission Induction; Survival Analysis; Treatment Outcome; Virus Activation | 2004 |
Treatment of Epstein-Barr virus-associated peripheral T-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Humans; Lymphoma, T-Cell, Cutaneous; Male; Skin Neoplasms | 2004 |
Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
Topics: Adolescent; B-Lymphocytes; Cell Line, Transformed; Cell Transformation, Viral; Chronic Disease; Cyclosporine; DNA, Viral; Drug Resistance; Epstein-Barr Virus Infections; Etoposide; Female; Hepatitis, Viral, Human; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Multiple Organ Failure; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2004 |
Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Dexamethasone; DNA-Binding Proteins; Epstein-Barr Virus Infections; Etoposide; Gene Rearrangement; Histiocytosis, Non-Langerhans-Cell; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia, Myelomonocytic, Acute; Male; Methotrexate; Myeloid-Lymphoid Leukemia Protein; Neoplasms, Second Primary; Nucleic Acid Synthesis Inhibitors; Polymerase Chain Reaction; Proto-Oncogenes; Time Factors; Topoisomerase II Inhibitors; Transcription Factors | 2004 |
Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
Topics: Adolescent; Bone Marrow Transplantation; Child, Preschool; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Male | 2005 |
Epstein-Barr virus infected natural killer cell lymphoma in a patient with hypersensitivity to mosquito bite.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Culicidae; Epstein-Barr Virus Infections; Etoposide; Glyoxal; Humans; Hypersensitivity; Ifosfamide; Insect Bites and Stings; Killer Cells, Natural; Lymph Nodes; Lymphocytes; Lymphoma; Male; Prednimustine; Skin | 2006 |
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Glucocorticoids; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Rituximab; Time Factors; Transplantation Chimera; Transplantation Conditioning; Vincristine; Virus Activation; Whole-Body Irradiation | 2005 |
A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.
Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Crohn Disease; Cytarabine; Epirubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Liver; Lymphoma, T-Cell, Peripheral; Lymphoproliferative Disorders; Male; Methylprednisolone; Pentostatin; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Spleen; Transplantation, Homologous; Vidarabine | 2006 |
Reactive hemophagocytic syndrome in a patient with polyarteritis nodosa associated with Epstein-Barr virus reactivation.
Topics: Aged; Antiviral Agents; Blood Transfusion; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Glucocorticoids; Herpesvirus 4, Human; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Polyarteritis Nodosa; Prednisolone | 2006 |
Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Epstein-Barr Virus Infections; Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Lymphohistiocytosis, Hemophagocytic; Male; Remission Induction; Transplantation, Homologous | 2007 |
Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society.
Topics: Child; Child, Preschool; Cyclosporine; Dexamethasone; DNA, Viral; Epstein-Barr Virus Infections; Etoposide; Female; Glucocorticoids; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infant; Male; Prednisolone; Remission Induction; Steroids | 1999 |
Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Blotting, Southern; Brain Neoplasms; Cell Division; Cell Transformation, Viral; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; In Situ Hybridization; Interferon-gamma; Interleukin-10; Karyotyping; Lymphocyte Activation; Lymphoma, Large B-Cell, Diffuse; Male; Polymerase Chain Reaction; Prednisolone; Receptors, Interleukin-2; T-Lymphocytes; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Vincristine | 2000 |
Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Appendicitis; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Intestinal Perforation; Killer Cells, Natural; Leucovorin; Lymphoma, T-Cell; Male; Methotrexate; Methylprednisolone; Nitrosourea Compounds; Nose Neoplasms; Prednisone; Skin Neoplasms; Splenic Neoplasms; Tumor Virus Infections; Vincristine | 2000 |
Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Male; Risk Factors; Survival Analysis; Treatment Outcome | 2001 |
Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Neoplasms, Second Primary | 2001 |
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Apoptosis Regulatory Proteins; Arabidopsis Proteins; bcl-X Protein; Biopolymers; Cysteine Endopeptidases; Drug Synergism; Enzyme Activation; Epstein-Barr Virus Infections; Etoposide; Fatty Acid Desaturases; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Infections; Humans; Immunocompromised Host; Immunologic Factors; Interferon-alpha; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Membrane Glycoproteins; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Thymidine; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Zidovudine | 2001 |
Intravenous immunoglobulin for hemophagocytic lymphohistiocytosis?
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Cyclosporine; Drug Administration Schedule; Epstein-Barr Virus Infections; Etoposide; Histiocytosis, Non-Langerhans-Cell; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Macrophage Activation; Patient Selection; Reproducibility of Results | 2002 |
Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Epstein-Barr Virus Infections; Etoposide; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; In Situ Hybridization; Lymphoma; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2002 |
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Epstein-Barr Virus Infections; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methylprednisolone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Optic Nerve Neoplasms; Radiotherapy, Adjuvant; Retinoblastoma; Rituximab; Thiotepa; Vincristine | 2002 |